Investigating intestinal farnesoid X receptor functions at the intestinal mucosal barrier and in the intestinal microbiota in a biliary obstruction mouse model
American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.08.2025 · 329 (2) · G313-G327
DOI: 10.1152/ajpgi.00223.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.08.2025. Verfasst von Yaoyao Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, Nanjing, People's Republic of China. Hauptthemen laut MEDLINE: Receptors, Cytoplasmic and Nuclear, Gastrointestinal Microbiome, Intestinal Mucosa, Cholestasis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Jiangsu Commission of Health (), Nanjing Municipal Health Bureau, | Graduate Research and Innovation Projects of Jiangsu Province (Graduate Research and Innovation Project).
Abstract (Originalsprache)
Intestinal barrier dysfunction and dysbiosis are critical in biliary obstructive diseases, making farnesoid X receptor (FXR) a potential therapeutic target. Our study shows that Fxr deficiency impairs barrier function and causes dysbiosis. In a biliary obstruction model, obeticholic acid (OCA) activation of Fxr protects against these effects. In addition, single-cell sequencing suggests that Fxr may regulate Reg3g, influencing intestinal functions. This research reveals the role of FXR and offers new molecular targets for the treatment of biliary obstructive diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Children's Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
- Department of Orthopaedics surgery, Affiliated Changzhou Children's Hospital of Nantong University, Changzhou, People's Republic of China.
- Department of Surgical Oncology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
ORCID-Profile: Yaoyao Cai, Weiwei Jiang
Förderung
- Jiangsu Commission of Health ()
- Nanjing Municipal Health Bureau
- | Graduate Research and Innovation Projects of Jiangsu Province (Graduate Research and Innovation Project)
- 江苏省教育厅 | Graduate Research and Innovation Projects of Jiangsu Province
Zitieren
APA
Cai, Y., Chen, X., Wang, H., Hou, L., Zheng, R., Wang, Y., Jiang, W., & Tang, W. (2025). Investigating intestinal farnesoid X receptor functions at the intestinal mucosal barrier and in the intestinal microbiota in a biliary obstruction mouse model. American Journal of Physiology-Gastrointestinal and Liver Physiology, 329(2), G313-G327. https://doi.org/10.1152/ajpgi.00223.2024
Vancouver
Cai Y, Chen X, Wang H, Hou L, Zheng R, Wang Y, et al. Investigating intestinal farnesoid X receptor functions at the intestinal mucosal barrier and in the intestinal microbiota in a biliary obstruction mouse model. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2025;329(2):G313-G327. doi:10.1152/ajpgi.00223.2024
BibTeX
@article{Cai2025,
author = {Cai, Yaoyao and Chen, Xintong and Wang, Hanfei and Hou, Li and Zheng, Ruifei and Wang, Yue and Jiang, Weiwei and Tang, Weibing},
title = {Investigating intestinal farnesoid X receptor functions at the intestinal mucosal barrier and in the intestinal microbiota in a biliary obstruction mouse model},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2025},
volume = {329},
number = {2},
pages = {G313--G327},
doi = {10.1152/ajpgi.00223.2024}
}
EUVIMED